The Exclusion of Patients with CKD in Prospectively Registered Interventional Trials for COVID-19-a Rapid Review of International Registry Data
- PMID: 32900842
- PMCID: PMC7608999
- DOI: 10.1681/ASN.2020060877
The Exclusion of Patients with CKD in Prospectively Registered Interventional Trials for COVID-19-a Rapid Review of International Registry Data
Keywords: COVID-19; chronic kidney disease; clinical trial.
Figures
References
-
- Strippoli GF, Craig JC, Schena FP: The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 15: 411–419, 2004. - PubMed
-
- Baigent C, Herrington WG, Coresh J, Landray MJ, Levin A, Perkovic V, et al. ; KDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology Conference Participants : Challenges in conducting clinical trials in nephrology: Conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) controversies conference. Kidney Int 92: 297–305, 2017. - PMC - PubMed
-
- World Health Organization: International Clinical Trials Registry Platform (ICTRP), 2020. Available at: https://www.who.int/ictrp/en/. Accessed April 22, 2020
-
- MedicinesComplete: The definitive online resource for drug and healthcare information, 2020. Available at: http://www.medicinescomplete.com. Accessed May 27, 2020
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
